Preliminary results of a randomized phase IIb double-blind 2x2 trial of low-dose tamoxifen and fenretinide for breast cancer prevention.

被引：0
|
作者：
Bonanni, B
Guerrieri-Gonzaga, A
Robertson, C
Serrano, D
Cazzaniga, M
Mora, S
Gulisano, M
Johansson, H
Galimberti, V
Intra, M
Latronico, A
Franchi, D
Pelosi, D
Decensi, A
机构：
[1] European Inst Oncol, Milan, Italy
[2] Univ Strathclyde, Glasgow, Lanark, Scotland
[3] Osped San Bortolo, Vicenza, Italy
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2005年 / 94卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S168 / S169
页数：2
相关论文
共 50 条
  • [1] Preliminary results on safety and activity of a randomized, double-blind, 2 X 2 trial of low-dose tamoxifen and fenretinide for breast cancer prevention in premenopausal women
    Guerrieri-Gonzaga, A
    Robertson, C
    Bonanni, B
    Serrano, D
    Cazzaniga, M
    Mora, S
    Gulisano, M
    Johansson, H
    Intra, M
    Latronico, A
    Franchi, D
    Pelosi, G
    Johnson, K
    Decensi, A
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (01) : 129 - 135
  • [2] A randomized double-blind 2x2 trial of low-dose tamoxifen and fenretinide for breast cancer prevention of high-risk premenopausal women
    Decensi, A.
    Robertson, C.
    Guerrieri-Gonzaga, A.
    Serrano, D.
    Cazzaniga, M.
    Gulisano, M.
    Johansson, H.
    Cassano, E.
    Moroni, S.
    Johnson, K.
    Bonanni, B.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [3] Circulating adiponectin levels as a predictive factor of breast cancer in a double-blind 2x2 phase II trial of low-dose tamoxifen and fenretinide for breast cancer prevention
    Gonzaga, A. Guerrieri
    Gandini, S.
    Johansson, H.
    Macis, D.
    Magni, P.
    Dozio, E.
    Lazzeroni, M.
    Gulisano, M.
    Decensi, A.
    Bonanni, B.
    EJC SUPPLEMENTS, 2010, 8 (02): : 9 - 9
  • [4] Randomized Double-Blind 2 X 2 Trial of Low-Dose Tamoxifen and Fenretinide for Breast Cancer Prevention in High-Risk Premenopausal Women
    Decensi, Andrea
    Robertson, Chris
    Guerrieri-Gonzaga, Aliana
    Serrano, Davide
    Cazzaniga, Massimiliano
    Mora, Serena
    Gulisano, Marcella
    Johansson, Harriet
    Galimberti, Viviana
    Cassano, Enrico
    Moroni, Simona M.
    Formelli, Franca
    Lien, Ernst A.
    Pelosi, Giuseppe
    Johnson, Karen A.
    Bonanni, Bernardo
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (23) : 3749 - 3756
  • [5] Preliminary results on safety and activity of a randomized, double-blind, 2 x 2 trial of low-dose tamoxifen and fenretinide for breast cancer prevention in premenopausal women (vol 24, pg 129, 2006)
    Guerrieri-Gonzaga, Aliana
    Robertson, Chris
    Bonanni, Bernardo
    Serrano, Davide
    Cazzaniga, Massimiliano
    Mora, Serena
    Gulisano, Marcella
    Johansson, Harriet
    Formelli, Franca
    Intra, Mattia
    Latronico, Antuono
    Franchi, Dorella
    Pelosi, Giuseppe
    Johnson, Karen
    Decensi, Andrea
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (19) : 3221 - 3221
  • [6] A randomized 2x2 biomarker trial of low-dose tamoxifen and fenretinide in premenopausal women at-high risk for breast cancer.
    Decensi, A
    Robertson, C
    Guerrieri-Gonzaga, A
    Cazzaniga, M
    Johansson, H
    Serrano, D
    Mora, S
    Gulisano, M
    Intra, M
    Greco, M
    Cassano, E
    Franchi, D
    Johnson, K
    Bonanni, B
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2003, 12 (11) : 1300S - 1300S
  • [7] A randomized 2x2 biomarker trial of low-dose tamoxifen and fenretinide in premenopausal women at-high risk for breast cancer.
    Decensi, A
    Bonanni, B
    Guerrieri-Gonzaga, A
    Robertson, C
    Cazzaniga, M
    Mariette, F
    Gulisano, M
    Latronico, A
    Franchi, D
    Johnson, K
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 97S - 97S
  • [8] Quality of Life in a Randomized Breast Cancer Prevention Trial of Low-Dose Tamoxifen and Fenretinide in Premenopausal Women
    Serrano, Davide
    Gandini, Sara
    Guerrieri-Gonzaga, Aliana
    Feroce, Irene
    Johansson, Harriet
    Macis, Debora
    Aristarco, Valentina
    Bonanni, Bernardo
    DeCensi, Andrea
    CANCER PREVENTION RESEARCH, 2018, 11 (12) : 811 - 817
  • [9] Early results from a double-blind, randomized phase IIB trial of difluoromethylorthine plus sulindac for colon cancer prevention.
    Meyskens, FL
    Pelot, D
    MacLaren, CE
    Lagerberg, W
    Li, KT
    Carpenter, P
    Gerner, E
    Goldschmid, S
    Kidao, J
    Ahnen, D
    Lawson, MJ
    McCracken, J
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2004, 13 (11) : 1904S - 1904S
  • [10] Prognostic Effect of Circulating Adiponectin in a Randomized 2 x 2 Trial of Low-Dose Tamoxifen and Fenretinide in Premenopausal Women at Risk for Breast Cancer
    Macis, Debora
    Gandini, Sara
    Guerrieri-Gonzaga, Aliana
    Johansson, Harriet
    Magni, Paolo
    Ruscica, Massimiliano
    Lazzeroni, Matteo
    Serrano, Davide
    Cazzaniga, Massimiliano
    Mora, Serena
    Feroce, Irene
    Pizzamiglio, Maria
    Sandri, Maria Teresa
    Gulisano, Marcella
    Bonanni, Bernardo
    DeCensi, Andrea
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (02) : 151 - 157
12345